ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intranasal Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4G14679
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Intranasal Vaccine Market Research Report 2023
BUY CHAPTERS

Global Intranasal Vaccine Market Research Report 2025

Code: QYRE-Auto-4G14679
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Abbott
Bharat Biotech
Antares Pharma
Injex Pharma GmbH
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co.,Ltd.
Changchun Baike Company
Serum Institute of India
GlaxoSmithKline PLC
Sanofi
BioDiem Ltd

Intranasal Vaccine Market Size

The global market for Intranasal Vaccine was valued at US$ 622 million in the year 2024 and is projected to reach a revised size of US$ 871 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Intranasal Vaccine Market

Intranasal Vaccine Market

Vaccines administered nasally
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intranasal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Vaccine.
The Intranasal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intranasal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intranasal Vaccine Market Report

Report Metric Details
Report Name Intranasal Vaccine Market
Accounted market size in year US$ 622 million
Forecasted market size in 2031 US$ 871 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH, BioDiem, PharmaJet and Crossject, Beijing Wantai Biopharmaceutical Co., Ltd., Changchun Baike Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intranasal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intranasal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intranasal Vaccine Market growing?

Ans: The Intranasal Vaccine Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Intranasal Vaccine Market size in 2031?

Ans: The Intranasal Vaccine Market size in 2031 will be US$ 871 million.

Who are the main players in the Intranasal Vaccine Market report?

Ans: The main players in the Intranasal Vaccine Market are Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH, BioDiem, PharmaJet and Crossject, Beijing Wantai Biopharmaceutical Co., Ltd., Changchun Baike Company

What are the Application segmentation covered in the Intranasal Vaccine Market report?

Ans: The Applications covered in the Intranasal Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Intranasal Vaccine Market report?

Ans: The Types covered in the Intranasal Vaccine Market report are Flu Vaccine, COVID-19 Vaccines

Recommended Reports

Nasal & Intranasal Markets

Vaccine Delivery & Adjuvants

Multivalent & Pediatric Vaccines

1 Intranasal Vaccine Market Overview
1.1 Product Definition
1.2 Intranasal Vaccine by Type
1.2.1 Global Intranasal Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Flu Vaccine
1.2.3 COVID-19 Vaccines
1.3 Intranasal Vaccine by Application
1.3.1 Global Intranasal Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Intranasal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intranasal Vaccine Revenue 2020-2031
1.4.2 Global Intranasal Vaccine Sales 2020-2031
1.4.3 Global Intranasal Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intranasal Vaccine Market Competition by Manufacturers
2.1 Global Intranasal Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intranasal Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intranasal Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intranasal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
2.8 Global Intranasal Vaccine Market Competitive Situation and Trends
2.8.1 Global Intranasal Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intranasal Vaccine Players Market Share by Revenue
2.8.3 Global Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intranasal Vaccine Market Scenario by Region
3.1 Global Intranasal Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intranasal Vaccine Sales by Region: 2020-2031
3.2.1 Global Intranasal Vaccine Sales by Region: 2020-2025
3.2.2 Global Intranasal Vaccine Sales by Region: 2026-2031
3.3 Global Intranasal Vaccine Revenue by Region: 2020-2031
3.3.1 Global Intranasal Vaccine Revenue by Region: 2020-2025
3.3.2 Global Intranasal Vaccine Revenue by Region: 2026-2031
3.4 North America Intranasal Vaccine Market Facts & Figures by Country
3.4.1 North America Intranasal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intranasal Vaccine Sales by Country (2020-2031)
3.4.3 North America Intranasal Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Vaccine Market Facts & Figures by Country
3.5.1 Europe Intranasal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intranasal Vaccine Sales by Country (2020-2031)
3.5.3 Europe Intranasal Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Intranasal Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intranasal Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Intranasal Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intranasal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intranasal Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Intranasal Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intranasal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intranasal Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intranasal Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intranasal Vaccine Sales by Type (2020-2031)
4.1.1 Global Intranasal Vaccine Sales by Type (2020-2025)
4.1.2 Global Intranasal Vaccine Sales by Type (2026-2031)
4.1.3 Global Intranasal Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Intranasal Vaccine Revenue by Type (2020-2031)
4.2.1 Global Intranasal Vaccine Revenue by Type (2020-2025)
4.2.2 Global Intranasal Vaccine Revenue by Type (2026-2031)
4.2.3 Global Intranasal Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Intranasal Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intranasal Vaccine Sales by Application (2020-2031)
5.1.1 Global Intranasal Vaccine Sales by Application (2020-2025)
5.1.2 Global Intranasal Vaccine Sales by Application (2026-2031)
5.1.3 Global Intranasal Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Intranasal Vaccine Revenue by Application (2020-2031)
5.2.1 Global Intranasal Vaccine Revenue by Application (2020-2025)
5.2.2 Global Intranasal Vaccine Revenue by Application (2026-2031)
5.2.3 Global Intranasal Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Intranasal Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Intranasal Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Intranasal Vaccine Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Intranasal Vaccine Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Company Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline Intranasal Vaccine Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India Intranasal Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Company Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bharat Biotech Intranasal Vaccine Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Antares Pharma
6.7.1 Antares Pharma Company Information
6.7.2 Antares Pharma Description and Business Overview
6.7.3 Antares Pharma Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Antares Pharma Intranasal Vaccine Product Portfolio
6.7.5 Antares Pharma Recent Developments/Updates
6.8 INJEX Pharma GmbH
6.8.1 INJEX Pharma GmbH Company Information
6.8.2 INJEX Pharma GmbH Description and Business Overview
6.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 INJEX Pharma GmbH Intranasal Vaccine Product Portfolio
6.8.5 INJEX Pharma GmbH Recent Developments/Updates
6.9 BioDiem
6.9.1 BioDiem Company Information
6.9.2 BioDiem Description and Business Overview
6.9.3 BioDiem Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BioDiem Intranasal Vaccine Product Portfolio
6.9.5 BioDiem Recent Developments/Updates
6.10 PharmaJet and Crossject
6.10.1 PharmaJet and Crossject Company Information
6.10.2 PharmaJet and Crossject Description and Business Overview
6.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PharmaJet and Crossject Intranasal Vaccine Product Portfolio
6.10.5 PharmaJet and Crossject Recent Developments/Updates
6.11 Beijing Wantai Biopharmaceutical Co., Ltd.
6.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
6.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolio
6.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Changchun Baike Company
6.12.1 Changchun Baike Company Company Information
6.12.2 Changchun Baike Company Description and Business Overview
6.12.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Changchun Baike Company Intranasal Vaccine Product Portfolio
6.12.5 Changchun Baike Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intranasal Vaccine Industry Chain Analysis
7.2 Intranasal Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Vaccine Production Mode & Process Analysis
7.4 Intranasal Vaccine Sales and Marketing
7.4.1 Intranasal Vaccine Sales Channels
7.4.2 Intranasal Vaccine Distributors
7.5 Intranasal Vaccine Customer Analysis
8 Intranasal Vaccine Market Dynamics
8.1 Intranasal Vaccine Industry Trends
8.2 Intranasal Vaccine Market Drivers
8.3 Intranasal Vaccine Market Challenges
8.4 Intranasal Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Abbott
Bharat Biotech
Antares Pharma
Injex Pharma GmbH
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co.,Ltd.
Changchun Baike Company
Serum Institute of India
GlaxoSmithKline PLC
Sanofi
BioDiem Ltd
List of Tables
 Table 1. Global Intranasal Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intranasal Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intranasal Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intranasal Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intranasal Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intranasal Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intranasal Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intranasal Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intranasal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intranasal Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intranasal Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intranasal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intranasal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intranasal Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intranasal Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Intranasal Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intranasal Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Intranasal Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intranasal Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Intranasal Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intranasal Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Intranasal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intranasal Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intranasal Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intranasal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intranasal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intranasal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intranasal Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intranasal Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intranasal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intranasal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intranasal Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intranasal Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intranasal Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intranasal Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intranasal Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intranasal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intranasal Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intranasal Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intranasal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intranasal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intranasal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intranasal Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intranasal Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intranasal Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intranasal Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intranasal Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Intranasal Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Intranasal Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Intranasal Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Intranasal Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intranasal Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intranasal Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Intranasal Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Intranasal Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intranasal Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intranasal Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Intranasal Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Intranasal Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Intranasal Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Intranasal Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intranasal Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intranasal Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Intranasal Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Intranasal Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intranasal Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Intranasal Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Intranasal Vaccine Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Intranasal Vaccine Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. GlaxoSmithKline Company Information
 Table 86. GlaxoSmithKline Description and Business Overview
 Table 87. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GlaxoSmithKline Intranasal Vaccine Product
 Table 89. GlaxoSmithKline Recent Developments/Updates
 Table 90. Serum Institute of India Company Information
 Table 91. Serum Institute of India Description and Business Overview
 Table 92. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Serum Institute of India Intranasal Vaccine Product
 Table 94. Serum Institute of India Recent Developments/Updates
 Table 95. Bharat Biotech Company Information
 Table 96. Bharat Biotech Description and Business Overview
 Table 97. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bharat Biotech Intranasal Vaccine Product
 Table 99. Bharat Biotech Recent Developments/Updates
 Table 100. Antares Pharma Company Information
 Table 101. Antares Pharma Description and Business Overview
 Table 102. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Antares Pharma Intranasal Vaccine Product
 Table 104. Antares Pharma Recent Developments/Updates
 Table 105. INJEX Pharma GmbH Company Information
 Table 106. INJEX Pharma GmbH Description and Business Overview
 Table 107. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. INJEX Pharma GmbH Intranasal Vaccine Product
 Table 109. INJEX Pharma GmbH Recent Developments/Updates
 Table 110. BioDiem Company Information
 Table 111. BioDiem Description and Business Overview
 Table 112. BioDiem Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. BioDiem Intranasal Vaccine Product
 Table 114. BioDiem Recent Developments/Updates
 Table 115. PharmaJet and Crossject Company Information
 Table 116. PharmaJet and Crossject Description and Business Overview
 Table 117. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. PharmaJet and Crossject Intranasal Vaccine Product
 Table 119. PharmaJet and Crossject Recent Developments/Updates
 Table 120. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
 Table 121. Beijing Wantai Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product
 Table 124. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Changchun Baike Company Company Information
 Table 126. Changchun Baike Company Description and Business Overview
 Table 127. Changchun Baike Company Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Changchun Baike Company Intranasal Vaccine Product
 Table 129. Changchun Baike Company Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Intranasal Vaccine Distributors List
 Table 133. Intranasal Vaccine Customers List
 Table 134. Intranasal Vaccine Market Trends
 Table 135. Intranasal Vaccine Market Drivers
 Table 136. Intranasal Vaccine Market Challenges
 Table 137. Intranasal Vaccine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intranasal Vaccine
 Figure 2. Global Intranasal Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intranasal Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Flu Vaccine Product Picture
 Figure 5. COVID-19 Vaccines Product Picture
 Figure 6. Global Intranasal Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Intranasal Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Intranasal Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Intranasal Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Intranasal Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Intranasal Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Intranasal Vaccine Report Years Considered
 Figure 15. Intranasal Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Intranasal Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Intranasal Vaccine Players: Market Share by Revenue in Intranasal Vaccine in 2024
 Figure 18. Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Intranasal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Intranasal Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Intranasal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Intranasal Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Intranasal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Intranasal Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Intranasal Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Intranasal Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Intranasal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Intranasal Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Intranasal Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Intranasal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Intranasal Vaccine by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Intranasal Vaccine by Type (2020-2031)
 Figure 52. Global Intranasal Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Intranasal Vaccine by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Intranasal Vaccine by Application (2020-2031)
 Figure 55. Global Intranasal Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 56. Intranasal Vaccine Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Intranasal Drug and Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Drug Delivery Technology Market Insights Forecast to 2030
Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Polyps Treatment Market Insights Forecast to 2030
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasal Spray Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Medicines and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Akabane Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glass Bottle for Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
African Horse Sickness Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intranasal Drug And Vaccine Delivery Device Market Research Report 2024
Global Technologies for Delivery of Proteins Antibodies and Nucleic Acids Market Insights Forecast to 2030
Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Pillow Mask Market Insights Forecast to 2030
Nasal Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intranasal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Injection of Vaccine Market Research Report 2024
Nasal Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orally Administered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions